Skandinaviska Enskilda Banken (SEB)’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,000
| Closed | -$4.62M | – | 909 |
|
|
2025
Q1 | $4.62M | Sell |
35,000
-243,711
| -87% | -$32.2M | 0.02% | 430 |
|
|
2024
Q4 | $23.3M | Hold |
278,711
| – | – | 0.11% | 161 |
|
|
2024
Q3 | $20.4M | Buy |
278,711
+19,590
| +8% | +$1.43M | 0.09% | 177 |
|
|
2024
Q2 | $17.7M | Buy |
259,121
+128,908
| +99% | +$8.83M | 0.09% | 190 |
|
|
2024
Q1 | $9M | Sell |
130,213
-160,718
| -55% | -$11.1M | 0.04% | 292 |
|
|
2023
Q4 | $20.8M | Sell |
290,931
-113,181
| -28% | -$8.1M | 0.12% | 166 |
|
|
2023
Q3 | $21M | Hold |
404,112
| – | – | 0.14% | 152 |
|
|
2023
Q2 | $25.6M | Buy |
404,112
+135,749
| +51% | +$8.59M | 0.17% | 123 |
|
|
2023
Q1 | $14.5M | Sell |
268,363
-104,713
| -28% | -$5.67M | 0.1% | 214 |
|
|
2022
Q4 | $19.8M | Sell |
373,076
-10,489
| -3% | -$555K | 0.15% | 156 |
|
|
2022
Q3 | $17.8M | Hold |
383,565
| – | – | 0.14% | 146 |
|
|
2022
Q2 | $21.9M | Sell |
383,565
-8,372
| -2% | -$478K | 0.16% | 129 |
|
|
2022
Q1 | $24M | Sell |
391,937
-4,342
| -1% | -$266K | 0.14% | 140 |
|
|
2021
Q4 | $20.7M | Buy |
396,279
+103,816
| +35% | +$5.41M | 0.11% | 176 |
|
|
2021
Q3 | $10.9M | Hold |
292,463
| – | – | 0.06% | 272 |
|
|
2021
Q2 | $11.9M | Buy |
292,463
+266,741
| +1,037% | +$10.9M | 0.07% | 254 |
|
|
2021
Q1 | $874K | Buy |
+25,722
| New | +$874K | 0.01% | 860 |
|